Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Indocyanine Green to Enhance Intraoperative Detection of Liver Tumors in Minimally Invasive Surgery
2023-508316-27-00Phase 4Authorised
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of indocyanine green in hepatic neoplasm, sponsored by Vall d'Hebron Research Institute. Primary endpoint: Intraoperative detection of liver tumors using IOUS and indocyanine green. Planned start Feb 2024; status: authorised.
02
Drugs
indocyanine green
03
Conditions
hepatic neoplasm
Beyond the preview
Go deeper on 2023-508316-27-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-508316-27-00.